Heidelberg Epignostix GmbH

About Heidelberg Epignostix GmbH

Heidelberg Epignostix develops precision cancer diagnostics through DNA methylation profiling and machine learning algorithms for accurate tumor classification. This technology enhances diagnostic accuracy, enabling healthcare providers to make informed decisions regarding cancer treatment and management.

```xml <problem> Accurate and precise diagnosis is crucial for optimal management of patients with cancer, but current methods for tumor classification can be inaccurate. This can lead to suboptimal treatment decisions and outcomes for cancer patients. </problem> <solution> Heidelberg Epignostix is developing software solutions for precision molecular diagnostics, leveraging DNA methylation profiling and machine learning for accurate tumor classification. Their technology aims to improve diagnostic accuracy, enabling healthcare providers to make more informed decisions regarding cancer treatment and management. By combining scientific and medical expertise with technical innovation, Heidelberg Epignostix seeks to personalize cancer treatments. </solution> <features> - Molecular tumor classification based on DNA methylation profiling. - Machine learning algorithms for enhanced diagnostic accuracy. - Software solutions for clinical use. </features> <target_audience> The primary audience includes healthcare providers and oncologists involved in cancer diagnosis, treatment, and management. </target_audience> ```

What does Heidelberg Epignostix GmbH do?

Heidelberg Epignostix develops precision cancer diagnostics through DNA methylation profiling and machine learning algorithms for accurate tumor classification. This technology enhances diagnostic accuracy, enabling healthcare providers to make informed decisions regarding cancer treatment and management.

Where is Heidelberg Epignostix GmbH located?

Heidelberg Epignostix GmbH is based in Heidelberg, Germany.

When was Heidelberg Epignostix GmbH founded?

Heidelberg Epignostix GmbH was founded in 2022.

How much funding has Heidelberg Epignostix GmbH raised?

Heidelberg Epignostix GmbH has raised 4630000.

Who founded Heidelberg Epignostix GmbH?

Heidelberg Epignostix GmbH was founded by Helge Lubenow.

  • Helge Lubenow - CEO
Location
Heidelberg, Germany
Founded
2022
Funding
4630000
Employees
8 employees
Major Investors
Carma Fund
Looking for specific startups?
Try our free semantic startup search

Heidelberg Epignostix GmbH

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Heidelberg Epignostix develops precision cancer diagnostics through DNA methylation profiling and machine learning algorithms for accurate tumor classification. This technology enhances diagnostic accuracy, enabling healthcare providers to make informed decisions regarding cancer treatment and management.

epignostix.com700+
cb
Crunchbase
Founded 2022Heidelberg, Germany

Funding

$

Estimated Funding

$4.6M+

Major Investors

Carma Fund

Team (5+)

Helge Lubenow

CEO

Company Description

Problem

Accurate and precise diagnosis is crucial for optimal management of patients with cancer, but current methods for tumor classification can be inaccurate. This can lead to suboptimal treatment decisions and outcomes for cancer patients.

Solution

Heidelberg Epignostix is developing software solutions for precision molecular diagnostics, leveraging DNA methylation profiling and machine learning for accurate tumor classification. Their technology aims to improve diagnostic accuracy, enabling healthcare providers to make more informed decisions regarding cancer treatment and management. By combining scientific and medical expertise with technical innovation, Heidelberg Epignostix seeks to personalize cancer treatments.

Features

Molecular tumor classification based on DNA methylation profiling.

Machine learning algorithms for enhanced diagnostic accuracy.

Software solutions for clinical use.

Target Audience

The primary audience includes healthcare providers and oncologists involved in cancer diagnosis, treatment, and management.

Heidelberg Epignostix GmbH - Funding: $4M+ | StartupSeeker